slides · global inventory
Table Data
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 16,285
Current window 9,181-9,210
Pages 543
Rows per page 30
Tool
9,181-9,210 of 16,285
11
The table follows standard financial reporting reconciliation format.Nexters | Results Presentation Deck | 11 slides · GDEV Inc.
Conference presentation Investor relations 1 hit
10
The slide presents three distinct financial tables with corresponding bulleted commentary for each section.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The table provides a standard financial reconciliation format.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
15
Includes a footnote regarding regulatory and legal matters.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
16
The slide provides a standard financial disclosure reconciling GAAP operating cash flow to a non-GAAP 'Adjusted free cash flow' metric.Nikola | Results Presentation Deck | 17 slides · Nikola
Conference presentation Investor relations Beat · Action1 hit
17
The table highlights a heavily pretreated population, with 77% having received 3 or more prior lines of therapy and 71% having received 2 or more prior ROS1 TKIs.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
28
Includes detailed clinical trial design, cohort definitions, and study objectives.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations 1 hit
30
The slide uses a structured table to segment the patient population based on treatment history and specific genetic mutations.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
34
Clinical trial design slide detailing patient population, objectives, and cohort structure.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
36
Clinical trial baseline characteristics table.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
37
Data cut-off: 8 Aug 2023. Includes detailed footnotes regarding specific patient events.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
40
Data cut-off: 8 Aug 2023. Source: Lin J.J. et al., AACR-NCI-EORTC 2023.Nuvalent | Investor Presentation Deck | 52 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
11
The slide uses a split-screen comparison between UK market ranking improvements and German volume growth metrics.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
35
Oatly | Results Presentation Deck | 39 slidesOatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
36
Includes footnotes explaining corporate costs, intersegment eliminations, restructuring costs, and legal settlements.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
37
The slide provides a detailed breakdown of financial metrics across EMEA, Americas, Asia, Corporate, and Eliminations, reconciling non-IFRS measures to Loss before tax.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
38
Includes footnotes explaining corporate allocations, intersegment eliminations, and specific transaction costs.Oatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
39
Oatly | Results Presentation Deck | 39 slidesOatly | Results Presentation Deck | 39 slides · Oatly
Conference presentation Investor relations 1 hit
20
Includes detailed line-item adjustments for non-GAAP financial reporting.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
21
The table provides a breakdown of non-GAAP adjustments for Q1, Q2, Q3, Q4, and full-year 2022.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
22
Includes a disclaimer regarding non-GAAP financial measures and merger-related adjustments.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Financials1 hit
03
Values are in thousands.P3 Health Partners | Results Presentation Deck | 4 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
04
P3 Health Partners | Results Presentation Deck | 4 slidesP3 Health Partners | Results Presentation Deck | 4 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
12
Slide 2 of 4 in a sequence.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Product1 hit
18
Includes a footnote regarding the calculation of reported diluted net earnings per share.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit
19
Includes 12-month, quarterly, and 9-month data points.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit
20
The table includes unaudited figures in millions, broken down by revenue stream (Advertising, Affiliate and subscription, Licensing and other).Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit
21
Includes unaudited figures in millions; footnote (1) defines subscriber scope.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit
22
The table includes data for 12 months ended 12/31/21, quarterly data for 2022, 12 months ended 12/31/22, quarterly data for 2023, and 9 months ended 9/30/23.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit
25
Includes detailed footnotes explaining specific adjustments like restructuring, impairment, and programming charges.Paramount | Investor Presentation Deck | 27 slides · Paramount Global
Conference presentation Investor relations Beat · Financials1 hit